Rho-Kinase as a Drug Target for the Treatment of Airway Hyperresponsiveness in Asthma
Reinoud Gosens, Dedmer Schaafsma, S.Adriaan Nelemans, Andrew J. Halayko
Abstract
Reinoud Gosens, Dedmer Schaafsma, S.Adriaan Nelemans, Andrew J. Halayko
Abstract
In asthma, inflammatory and structural cells contribute to increased bronchoconstriction acutely and more chronically to airway remodelling. Current asthma therapy doesnt inhibit these features satisfactorily. This review discusses Rho-kinase as a potential drug target, since increasing evidence suggests a central role for this pathway in acute and chronic airway hyperresponsiveness. Keywords: Airway remodelling, airway smooth muscle, airway inflammation, Y-27632, fasudil
OpenAlex reports 64 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In asthma, inflammatory and structural cells contribute to increased bronchoconstriction acutely and more chronically to airway remodelling. Current asthma therapy doesnt inhibit these features satisfactorily. This review discusses Rho-kinase as a potential drug target, since increasing evidence suggests a central role for this pathway in acute and chronic airway hyperresponsiveness. Keywords: Airway remodelling, airway smooth muscle, airway inflammation, Y-27632, fasudil
Key concepts: Fasudil, Bronchoconstriction, Airway hyperresponsiveness, Medicine, Asthma, Airway, Immunology, Bronchial hyperresponsiveness